On April 23rd 2019, the health data company Longenesis signed an agreement with the leading South Korean medical provider, Gil Medical Centre. The main aim towards the merger is to implement a blockchain medical data management platform.
Reportedly the two platforms intend to develop the blockchain powered platform based on Bitfury’s Exonum blockchain framework. Asides from streamlining health data collection, the blockchain based platform also aims to;
- Enable transparent patient consent management
- Improve medical research processes
- Address each patient’s specific compliance needs with the Health Insurance Portability and Accountability Act (HIPAA) and General Data Protection Regulation (GDPR) regulations since the hospital also provides services to foreigners.
About Longenesis
Longenesis, a partnership between Bitfury and the leading AI that uses deep learning for drug discovery, Insilico Medicine, prides itself as the world’s most advanced life data escrow. The platform’s main aim is to deliver the future of medicine and data analytics through integration of the best AI and Blockchain solutions available. Since Longenesis is built on blockchain technology, patient’s health records are securely stored and can be easily tracked. The platform also utilizes smart contracts and provides new developments in the healthcare ecosystem.
Earlier in April, Longenesis and Bitfury jointly launched the production of a blockchain based consent management system for the healthcare industry. According to a news source, the launch addressed issues with the management of user consent for both ongoing and upcoming research endeavours, the streamlining of data collection for medical research and the GDPR and HIPAA.
With Longenesis’ health data management solution, GI Medical Centre will be able to easily and securely store and manage data of individual patients and give full control of data usage and access back to patients.
The CEO of Longenesis, Garri Zmudze was quite honoured by the merger.
“Gil General Hospital has a splendid reputation for being on the edge of adopting latest innovation. We are honoured to mark our Korean presence with a partnership like such,” he said.
The merger will also allow Gil Medical centre to effectively manage consent forms and status for individual researchers.
